These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 413735)

  • 21. Estrogen receptor in malignant melanoma: fact or artefact?
    Zava DT; Goldhirsch A
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1151-9. PubMed ID: 6311560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of endogenous proteases on the distribution of tyrosinase isozymes in Harding-Passey mouse melanoma.
    Martinez JH; Solano F; Lozano JA
    Cell Biochem Funct; 1989 Jan; 7(1):21-6. PubMed ID: 2502324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of tyrosinase by dihydroxy phenyl derivatives.
    Karg E; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(6):521-4. PubMed ID: 2575328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of sulfhydryl compounds in mammalian melanogenesis: the effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway.
    Jara JR; Aroca P; Solano F; Martinez JH; Lozano JA
    Biochim Biophys Acta; 1988 Nov; 967(2):296-303. PubMed ID: 2903772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structural factors and the DOPA oxidase activity of membrane-bound tyrosinase].
    Shtol'ko VN; Kol'tover VK; Il'in AV; Vasil'eva LS; Bogdanov GN
    Dokl Akad Nauk SSSR; 1979; 244(4):1009-12. PubMed ID: 104854
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory effect of benzenethiol on the cresolase and catecholase activities of mushroom tyrosinase.
    Saboury AA; Zolghadri S; Haghbeen K; Moosavi-Movahedi AA
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):711-7. PubMed ID: 17252944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R; Pomerantz SH; Marshall S; Lerner AB
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma.
    Nishioka K
    FEBS Lett; 1977 Aug; 80(1):225-8. PubMed ID: 408193
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
    Thody AJ; Oliver I; Sherbet GV
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inability to demonstrate hydroxylation of tyrosine by murine melanoma "tyrosinase" (L-DOPA oxidase), using the tritiated water assay technique.
    Shapiro HC; Edelstein LM; Patel RP; Okun MR; Blackburn M; Snyder M; Brennan T; Wilgram G
    J Invest Dermatol; 1979 Apr; 72(4):191-3. PubMed ID: 107247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity.
    Hearing VJ; Ekel TM; Montague PM; Hearing ED; Nicholson JM
    Arch Biochem Biophys; 1978 Jan; 185(2):407-18. PubMed ID: 415664
    [No Abstract]   [Full Text] [Related]  

  • 33. Bleomycin enhances the tyrosinase activity of human malignant melanoma cells in culture.
    Bernd A; Altmeyer P; Schäfer G; Marsch WC; Holzmann H
    Pharmacol Res Commun; 1986 Nov; 18(11):1075-91. PubMed ID: 2432621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some properties of Bufo bufo tyrosinase during development.
    Miranda M; Botti D; Di Cola M; Ragnelli AM
    Experientia; 1981; 37(9):938-9. PubMed ID: 6795053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of polyamines on tyrosinase activity.
    Galindo JD; Martinez JH; Lopez-Ballester JA; Peñafiel R; Solano F; Lozano JA
    Biochem Int; 1987 Dec; 15(6):1151-8. PubMed ID: 3125836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanogenuria as consequence of elevated tyrosinase activity in melanoma.
    Duchon J; Matous B; Pavel S
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):139-44. PubMed ID: 97931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of 6-hydroxydopa by human tyrosinase.
    Hansson C; Rorsman H; Rosengren E; Wittbjer A
    Acta Derm Venereol; 1985; 65(2):154-7. PubMed ID: 2408419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line.
    DiSorbo DM; Harris NA; Nathanson L
    Cancer Res; 1984 May; 44(5):1752-5. PubMed ID: 6424929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5,6-Dihydroxyindole oxidation by mammalian, mushroom and amphibian tyrosinase preparations.
    Miranda M; Botti D; Bonfigli A; Arcadi A
    Biochim Biophys Acta; 1985 Aug; 841(2):159-65. PubMed ID: 3926006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oxidation of hydroxylated aromatic compounds with tyrosinase].
    Beyer C
    Dermatol Monatsschr; 1983; 169(11):711-4. PubMed ID: 6420210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.